Wednesday, July 1, 2015

Daniel Hoffman

Why pharma can't adapt to the changing health environment

Wednesday, June 24, 2015, 12:48 PM
In nearly every sector of health care, competing companies are acting aggressively to position themselves for prospering in a rapidly changing environment. Consider first the provider segment. Hospital-based systems are gobbling up physician practices to the point where investment bank Credit Suisse... Read more

Trans-Pacific Partnership: Pharma's payoff for Obamacare neutrality

Wednesday, June 17, 2015, 11:08 AM
In 1993 the new Clinton administration decided to make health care reform the signature issue of its first term. Bill Clinton appointed his wife to pilot the initiative, but the entire effort was botched from the get-go. Dubbed Hillarycare by the media, the package was an unwieldy piece of Rube Goldberg... Read more

Health insurers balance long- and short-term moves but can pharma?

Monday, June 8, 2015, 10:41 AM
Commercial success for a new drug brand increasingly depends on whether and, how much, third-party payers will reimburse for it. As more physicians work for large, hospital-based networks, their decision-making role in a drug's success passes to discriminating private insurers and those provider networks... Read more

One week, three lessons for pharma

Friday, May 29, 2015, 12:31 PM
The past week in pharma was one of those times when just setting the news items alongside one another in the proper order can tell someone a lot about the industry. Here are a few lessons to be learned from assembling the jigsaw puzzle. 1. If anyone still doubted it, the emerging markets story is... Read more

When a pharma spokesman advocates value-based pricing

Thursday, May 21, 2015, 4:55 PM
The Forbes columnist and pharma cheerleader, John La Mattina, left Pfizer in 2008 as their R&D head with a $22.6 million package after spending $1 billion of the company's money on an HDL-cholesterol enhancer that never got past the FDA. This week he wrote an item attacking two members of the... Read more

Less research training in medical school? That's actually good

Wednesday, May 13, 2015, 3:41 PM
In Sunday's Health section of the Inquirer, reporter Ilene Raymond Rush interviewed the dean of Temple's medical school, Arthur Feldman. The dean tried to advance an agenda of academic empire building by bemoaning the fact that medical students today receive less research training than in the past... Read more

Which long-term road for GlaxoSmithKline

Thursday, May 7, 2015, 9:35 AM
GlaxoSmithKline (GSK), the British pharmaceutical company with U.S. operations in the Philadelphia area, reported 2015 first quarter earnings this morning. The numbers tell a dismal story. Sales were flat compared to the same period last year, even as revenue from prescription medicines declined... Read more

Drug pricing: The problem and some band-aids

Wednesday, April 29, 2015, 12:53 PM
Two stories surfaced this week that provide more examples of how increasing drug prices have gotten totally out of hand. In the first one, a study in the medical journal Neurology tracked prices for multiple sclerosis (MS) medications during the past dozen years and uncovered an "alarming rise" that... Read more

Self-dealing physicians and a bad trade deal

Monday, April 20, 2015, 10:35 AM
The costs of health care and affordable access to it are made worse by high drug prices that keep rising many times faster than the cost living. The pharmaceutical industry deserves the big share of blame for drug prices, but prescriptions account for only a little more than 10% of this country's total... Read more

Two questionable ways to develop new drugs

Wednesday, April 8, 2015, 10:33 AM
A substantial and growing number of people working in pharma R&D are painfully aware that the industry's “strategic partnering” approach to drug development requires more time and money to bring new products to market. Yet despite this reality of a naked emperor, pharma remains resolutely... Read more
About this blog

Check Up covers regional health news and a wide array of healthcare topics from pharmaceutical happenings to patient safety. Read about some of our bloggers here.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Hooman Noorchashm, M.D., Ph.D. Cardiothoracic surgeon in the Philadelphia area
Amy J. Reed, M.D., Ph.D. Anesthesiologist and Surgical Intensivist in the Philadelphia Area
Latest Health Videos
Also on Philly.com:
letter icon Newsletter